TIDMAMYT

RNS Number : 0827N

Amryt Pharma PLC

04 May 2018

4 May 2018

AIM: AMYT

ESM: AYP

Amryt Pharma plc

("Amryt" or the "Company")

Posting of Annual Report 2017 and Notice of AGM

Amryt, the biopharmaceutical company focused on rare and orphan diseases, announces that copies of the Annual Report for the year ended 31 December 2017 have today been sent to shareholders along with the Notice of Annual General Meeting ("AGM"). Copies are also available from the Company's website, www.amrytpharma.com.

The AGM will be held at 10am on 5 June 2018 at Holiday Inn London Mayfair, 3 Berkeley Street, Mayfair, London W1J 8NE.

Enquiries:

 
                                       +353 (1) 518 
 Amryt Pharma plc                       0200 
 Joe Wiley, CEO 
  Rory Nealon, CFO/COO 
 
                                       +44 (0) 20 
 Shore Capital                          7408 4090 
 Nomad and Joint Broker 
 Edward Mansfield, Mark 
  Percy, Daniel Bush 
 
                                       +353 (1) 679 
 Davy                                   6363 
 ESM Adviser and Joint 
  Broker 
 John Frain, Anthony Farrell 
                                       +44 (0) 20 
 Stifel                                 7710 7600 
 Joint Broker 
 Jonathan Senior, Ben 
  Maddison 
                                       +44 (0) 20 
 Consilium Strategic Communications     3709 5700 
 Financial PR Adviser 
  Amber Fennell 
  Matthew Neal

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSSWFIDFASEDI

(END) Dow Jones Newswires

May 04, 2018 02:00 ET (06:00 GMT)

Amryt Pharma (LSE:AMYT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Amryt Pharma Charts.
Amryt Pharma (LSE:AMYT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Amryt Pharma Charts.